METHODS	In this double-blind , placebo-controlled , parallel-group , international study , infants ( n = 149 ) with clinical or EEG evidence of refractory POS were randomly allocated ( 1:1:1:1 ) to receive adjunctive topiramate 5 , 15 , or 25 mg/kg/d or placebo for 20 days .\